AVNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AVNT is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has some supportive fundamentals and a decent Wall Street target reset higher, but the current price action is weak, options sentiment is bearish, hedge funds are selling, and the latest quarter showed only modest revenue growth with weaker earnings. Since the user wants a direct answer and is unwilling to wait for an ideal entry, the best call is to hold off rather than buy today.
The technical setup is short-term bearish to neutral. AVNT closed at 35.76, below the prior close of 36.52, and near support at 35.634 with downside risk toward 34.646. MACD histogram is negative and expanding, which points to fading momentum. RSI_6 at 44.95 is neutral, not oversold enough to suggest a strong rebound. Moving averages are converging, so the trend is not showing clear strength. Overall, price is weakening and not presenting a strong long entry today.
["Q1 2026 revenue rose 2.52% year over year to $847.4M, showing top-line growth.", "Gross margin improved to 32.17%, indicating better operating efficiency.", "Q1 adjusted EPS was $0.83, and consensus Q2 EPS is projected at $0.88.", "Morgan Stanley and Wells Fargo both raised price targets recently, suggesting analysts still see upside if execution continues.", "Congress trading data shows 1 net purchase and no sales in the past 90 days, a mildly positive signal."]
["KeyBanc downgraded AVNT to Sector Weight from Overweight on concerns about rising raw material costs.", "Hedge funds are selling, with selling up 319.69% over the last quarter.", "Current price momentum is negative, with MACD worsening and the stock trading below the recent pivot.", "Q1 net income and EPS declined sharply year over year despite revenue growth.", "CEO transition news may add near-term uncertainty."]
In Q1 2026, Avient posted revenue of $847.4M, up 2.52% year over year, which shows modest growth. Gross margin improved to 32.17%, a positive sign for pricing and mix. However, net income fell to $55.7M and EPS dropped to $0.61, both down sharply year over year, indicating earnings were weaker than the revenue trend. The quarter was decent on sales and margin, but not strong enough to justify an immediate buy for a long-term beginner investor.
Analyst sentiment is mixed but still somewhat constructive. Recent target hikes from Morgan Stanley, Wells Fargo, Baird, and KeyBanc earlier in February lifted targets into the mid-$40s to mid-$50s, while ratings ranged from Equal Weight to Overweight/Neutral. However, KeyBanc downgraded the stock on March 4 to Sector Weight due to rising raw material costs. Overall, Wall Street sees some upside potential, but the latest tone is more cautious than bullish. Pros: improving execution, higher price targets, possible margin upside if demand recovers. Cons: rising input costs, only modest growth, and at least one fresh downgrade.
